Biotec Services International has completed validation of their latest clinical supply facility expansion.
Biotec Services International has completed validation of its latest clinical supply facility expansion, adding almost 50% to the company’s clinical trial packaging, storage and distribution capacity.
As requested by clients, Biotec has increased refrigerated storage and packaging capacity by over 400%, and more than doubled its capacity to handle and store cell therapies and other advanced medicinal products. Furthermore, the company has acquired additional land adjacent to their current site for future capacity and capability expansions.
Biotec has also invested in enhancements to its existing operational facilities. For example, by implementing sliding walls between some of their smaller packaging rooms, Biotec is now able to scale-up room size to accommodate larger equipment such as automated labelling lines. This capability further enhances the company’s ability to efficiently manage its growing pipeline of Phase III projects.
In September 2014, Biotec was acquired by Packaging Coordinators Inc. (PCI), a global leader in drug development services. The acquisition and the completion of the Bridgend expansion further demonstrates PCI’s significant ongoing investment in clinical trial supply services. The Biotec site, which specialises in the management of temperature-sensitive products, has expertise in handling products at temperatures ranging from +25ºC down to -196ºC.
Dr Fiona Withey, managing director, UK Clinical Services at PCI, noted "Biotec’s business has grown as a result of our expertise in the packaging and distribution of temperature-sensitive biopharmaceutical products, and our ability to efficiently manage our clients’ projects regardless of their size. By increasing our temperature-controlled capacity, and designing flexibility into our operations, our recent investments illustrate our continued commitment to these key attributes of our business."